Physician profile
Matthew C Graham
NPI 1184105645
$1,641.23
in general payments reported to CMS, 2019-2025
12 companies · $207 in 2025
The $207 reported for 2025 was more than what 76% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.62 · 2020: $36.68 · 2021: $13.05 · 2022: $127 · 2023: $1,108 · 2024: $122 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950 · Travel and Lodging: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.29 |
| Travel and Lodging | $486.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,122.97 | 2022-2025 | |
| Align Technology, INC. | $123.65 | 2020-2023 | Invisalign First - Comprehensive |
| Solventum Corporation | $106.49 | 2025 | 3m Clinpro |
| Dentsply Sirona INC | $85.32 | 2020-2025 | Endo Activator, Astra Tech Implant System, Waveone Gold Conform Fit |
| Straumann USA LLC | $43.23 | 2025 | |
| Nobel Biocare USA | $39.21 | 2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $27.62 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $22.45 | 2024 | Exparel |
| Kerr Corporation | $18.89 | 2023 | Endodontics |
| Voco America INC. | $18.64 | 2024 | Grandio So, Calcicur, Grandio So Heavy Flow |
| 3m Company | $17.15 | 2022 | |
| Envista Holdings Corporation | $15.61 | 2024 | Harmonize |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.